$FULC
Fulcrum Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.69
▲+0.27%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateFulcrum Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is FULC up today? It is at $3.69 (+0.27%), and our scanner flagged it 33 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment FULC spikes, and full due diligence on FULC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $FULC 33 times in the last 30 days. Create a free account to track $FULC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on FULC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FULC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +51K 0.07% of company | added 0.7% | 7.08M | $179K at $3.52 | Jul 17, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +117K 0.2% of company | added 1.7% | 7.03M | $415K at $3.56 | Jul 16, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +107K 0.1% of company | added 1.6% | 6.91M | $382K at $3.56 | Jul 15, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +130K 0.2% of company | added 1.9% | 6.81M | $461K at $3.56 | Jul 14, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +13K 0.02% of company | added 0.2% | 6.68M | $46K at $3.54 | Jul 13, 26 |
Ezekowitz Alan Director | Sold (automatic/other) | -18K 0.02% of company | sold 62% | 11K | $66K at $3.65 | Jun 26, 26 |
Gould Robert J Director | Sold (automatic/other) | -15K 0.02% of company | sold 3.2% | 455K | $161K at $10.72 | Feb 2, 26 |
Gould Robert J Director | Sold (automatic/other) | -15K 0.02% of company | sold 3.1% | 470K | $178K at $11.87 | Jan 2, 26 |
Oltmans Curtis Gale Officer | Sold (automatic/other) | -3K | sold 25% | 10K | $45K at $12.92 | Dec 15, 25 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -4.18M 5.5% of company | sold 41% | 6.05M | $55.7M at $13.33 | Dec 8, 25 |
Gould Robert J Director | Sold (automatic/other) | -15K 0.02% of company | sold 3.0% | 485K | $165K at $11.03 | Nov 19, 25 |
Tourangeau Greg Officer | Sold (automatic/other) | -498 | sold 3.4% | 14K | $3K at $5.06 | May 8, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on FULC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FULC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
FULC last traded at $3.69, up 0.27% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Fulcrum Therapeutics, Inc. Common Stock (FULC) is next expected to report earnings on Wednesday, November 4, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The FULC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged FULC 33 times in the last 30 days.
FULC (Fulcrum Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $282M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge FULC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$FULC discussion
Sign in to ask a question or join the discussion.